A new dimension of potential resources in innovation: A wider scope of patent claims can lead to new functionality development
A new dimension of potential resources in innovation: A wider scope of patent claims can lead to new functionality development
复制标题
DOI：
10.1016/j.technovation.2005.06.002
复制
发表时间：
2006-07
期刊：
影响因子：
12.5
通讯作者：
T. Saiki;Yuji S Akano;C. Watanabe;Y. Tou
中科院分区：
文献类型：
--
作者：
T. Saiki;Yuji S Akano;C. Watanabe;Y. Tou
尽管人们对在超级竞争中提高技术对生产率的贡献抱有很高的期望，但日本高技术产业的技术生产率一直在下降，竞争力下降。解决这一扭曲陷阱的唯一办法是将目前研发、技术存量和生产之间的恶性循环转变为良性循环。在财政投资受到很大限制的情况下，实现良性循环的一个切实可行的解决办法是有效利用创新方面的潜在资源。扩大专利权范围可能是一个巧妙的触发器，导致一个良性循环，涉及新功能的开发、技术生产力的提高、产量的增加、更大的研发投资和可持续的更广泛的专利权范围。日本专利局推出了修订的审查指南（1993年6月审查指南），包括专利申请的描述要求。这促使领先的高技术公司扩大了申请专利的范围，并成功地建立了上述良性循环，从而表明了创新潜在资源的新层面的重要性。本文通过对日本本土和美国资本的制药企业的技术管理努力进行实证分析，对上述假设进行了论证。从研究中获得的一个值得注意的启示是，虽然拥有本土资本的领先制药公司通过更广泛的专利要求构建了一个良性循环，并因此实现了新的功能开发，但拥有美国资本的公司表现出更高的绩效水平。
Notwithstanding a significant expectation to increase the contribution of technology to productivity in megacompetition, the productivity of technology in Japan's high-technology industry has been declining, resulting in a decrease in competitiveness. The only solution to this twisted trap is to shift the current vicious cycle between R&D, technology stock and production to a virtuous cycle. Given strong constraints in fiscal investment, a practical solution to achieving a virtuous cycle is effective utilization of potential resources in innovation. A wider scope for patent claims can be an ingenious trigger leading to a virtuous cycle involving new functionality development, increased productivity of technology, production increases, greater R&D investment and a sustainable wider scope of patent claims. Japan's Patent Office introduced the Revised Examination Guideline (June 1993 Examination Guideline), including description requirements for patent applications. This induced leading high-technology firms to broaden their scope relative to claiming patents and succeeded in constructing the foregoing virtuous cycle, thereby demonstrating the significance of a new dimension of potential resources in innovation. On the basis of an empirical analysis focusing on techno-managerial efforts by Japan's pharmaceutical firms with both indigenous and the US capital, this paper attempts to demonstrate the foregoing hypothetical view. A noteworthy implication obtained from the research is that while leading pharmaceutical firms with indigenous capital have constructed a virtuous cycle by means of a wider scope of patent claims and have achieved new functionality development as a result, firms with the US capital have demonstrated a higher level of performance.